Active Ingredient History

NOW
  • Now
Encenicline is a selective partial agonist of the α7 nicotinic receptor. It was in phase III clinical trials for the treatment of cognitive impairment in schizophrenia, unfortunately it failed to meet the study endpoints in 2016.   Wikipedia

More Chemistry
7-chloro-n-quinuclidin-3-yl-benzo(b)thiophene-2-carboxamide | encenicline | encenicline hydrochloride | evp-6124 | mt-4666 | n-(7-chloro-n-quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue